Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

SRSF2 Mutation Cooperates with ASXL1 Mutation to Promote the Development of Myeloproliferative Variant of Chronic Myelomonocytic Leukemia

Jiaojiao Bai, Chen Qiu, Ming Yao, Chengxin Deng, Minming Li, Suxia Geng, Junfei Huang, Yangpeng Chen, Yuan Zhou, Xin Du

Blood (2024) 144 (Supplement 1): 6690.

https://doi.org/10.1182/blood-2024-205576

Published: 2024

Journal Articles

Single-Cell Analysis Reveals Altered Tumor Microenvironments of Relapse/ Refractory and Remission-Associated Acute Myeloid Leukemia Treated By ABC-14 Regimen

Xin Huang, Minming Li, Ping Wu, Chengxin Deng, Zesheng Lu, Yulian Wang, Suxia Geng, Chengwei Luo Luo, Peilong Lai, Xin Du, Jianyu Weng

Blood (2024) 144 (Supplement 1): 5802.

https://doi.org/10.1182/blood-2024-204516

Published: 2024

Journal Articles

MRD-Driven Prophylactic or Pre-Emptive Intervention with Chidamide-Based Treatment for High-Risk AML Relapse Post-Transplantation: A Real-World Experience from a Chinese Single Center

Ping Wu, Wei Ling, Chengwei Luo Luo, Lisi Huang, Ruohao Xu, Xiaoling Liang, Jiaqi Tan, Jinghua Wang, Peilong Lai, Suijing Wu, Birong Li, Haijie Huang, Suxia Geng, Xin Du, Jianyu Weng

Blood (2024) 144 (Supplement 1): 1575.

https://doi.org/10.1182/blood-2024-210697

Published: 2024

Journal Articles

Treatment-Free Remission Era: BCR-ABL1 mRNA Transcript Level <5% at 3 Months Predicts 24-Month Deep Molecular Response and Better Survival

Lisi Huang, Suxia Geng, Yulian Wang, Zesheng Lu, Chengxin Deng, Xin Huang, Minming Li, Lingji Zeng, Qiong Luo, Peilong Lai, Xin Du, Jianyu Weng

Blood (2023) 142 (Supplement 1): 4545.

https://doi.org/10.1182/blood-2023-185222

Published: 2023

Journal Articles

Efficacy and Safety Analysis of Venetoclax Combined with Azacitidine in Real-World Treatment of Patients with AML

Xin Huang, Chengxin Deng, Minming Li, Zesheng Lu, Ping Wu, Qiong Luo, Suxia Geng, Lingji Zeng, Yulian Wang, Hui Zhou, Jianyu Weng, Xin Du

Blood (2023) 142 (Supplement 1): 5941.

https://doi.org/10.1182/blood-2023-186010

Published: 2023

Journal Articles

Multi-Omics Reveals Azacitidine Partially Restores Hematopoiesis-Supportive Functions in Mesenchymal Stromal Cells from Patients with Chronic Myelomonocytic Leukemia

Ruohao Xu, Suxia Geng, Lingji Zeng, Chengxin Deng, Xin Huang, Minming Li, Ping Wu, Peilong Lai, Jianyu Weng, Xin Du

Blood (2023) 142 (Supplement 1): 3221.

https://doi.org/10.1182/blood-2023-189197

Published: 2023

Journal Articles

Artesunate Attenuate Chronic Graft-Versus-Host Disease By Regulating Th17/Treg Balance

Chen Xiaomei, Jianyu Weng, MD, Peilong Lai, Xin Huang, Wang Yulian, Suxia Geng, Liyan Guo, Tian Huang, Lingji Zeng, Xin Du, MD PhD

Blood (2018) 132 (Supplement 1): 5680.

https://doi.org/10.1182/blood-2018-99-114556

Published: 2018

Journal Articles

Comparison of the 5 Year Medical Outcome and Quality of Life of Patients with Chronic Myeloid Leukemia Treated with Imatinib or Allogeneic Transplant

Lisi Huang, Xin Du, Jianyu Weng, MD, Peilong Lai, Zesheng Lu, Ping Wu, Suijing Wu, PhD, Chengwei Luo, Xin Huang, Suxia Geng

Blood (2015) 126 (23): 2118.

https://doi.org/10.1182/blood.V126.23.2118.2118

Published: 2015

Journal Articles

Predictive Factors of Treatment Response to Hypomethylating Agents in Patients with Myelodysplastic Syndrome

Ping Wu, Xin Du, Jianyu Weng, Chengxin Deng, Suxia Geng, Zesheng Lu, Peilong Lai, Xin Huang, Chengwei Luo

Blood (2015) 126 (23): 5199.

https://doi.org/10.1182/blood.V126.23.5199.5199

Published: 2015

Journal Articles

Analysis of the Expression of PHTF1 and Related Genes in Acute Lymphoblastic Leukemia

Xin Huang, Suxia Geng, Jianyu Weng, Zesheng Lu, Linji Zeng, Minming Li, Chengxin Deng, Xiuli Wu, Yangqiu Li, Xin Du

Blood (2015) 126 (23): 4988.

https://doi.org/10.1182/blood.V126.23.4988.4988

Published: 2015

Journal Articles

The Expression of the Co-Inhibitory Molecule PD-1 and Its Ligand PD-L1 in Patients with MDS

Suxia Geng, Jianyu Weng, Xin Huang, Ping Wu, Chengxin Deng, Peilong Lai, Xin Du

Blood (2015) 126 (23): 5212.

https://doi.org/10.1182/blood.V126.23.5212.5212

Published: 2015

Journal Articles

Effects of Decitabine and Homoharringtonine in Combination in Leukemia Cell Lines

Suxia Geng, Han Yao, Jianyu Weng, Xin Huang, Ping Wu, Chengxin Deng, Zesheng Lu, Xin Du

Blood (2015) 126 (23): 5229.

https://doi.org/10.1182/blood.V126.23.5229.5229

Published: 2015

Journal Articles

Persistent Clonal Expansion of Vδ3 and Vδ4 T Cells in T-ALL Case with Minimal Residual Disease after HSCT

Ling Xu, Jianyu Weng, PhD, Xin Huang, Shaohua Chen, Suxia Geng, Lijian Yang, Suijing Wu, PhD, Suming Huang, PhD, Du Xin, PhD, Yangqiu Li, MD

Blood (2014) 124 (21): 5885.

https://doi.org/10.1182/blood.V124.21.5885.5885

Published: 2014

Journal Articles

CD8α + Jagged2 high CD11b high Regulatory Dendritic Cells Prevent Acute Gvhd

Jianyu Weng, M.D., Xin Huang, Ping Wu, Peilong Lai, Yueying Li, M.D., Lin Xu, M.D., Suxia Geng, Xin Du, MD

Blood (2013) 122 (21): 5428.

https://doi.org/10.1182/blood.V122.21.5428.5428

Published: 2013

Journal Articles

A New Murine Model Of Chronic Graft Versus Host Disease

Xin Huang, Jianyu Weng, M.D., Ping Wu, Jiaqi Tong, Peilong Lai, Suxia Geng, Xin Du, MD

Blood (2013) 122 (21): 5429.

https://doi.org/10.1182/blood.V122.21.5429.5429

Published: 2013

Journal Articles

The Evolution of Malignant and Reactive γδ+T Cell Clones in Relapse T-ALL After Allogeneic Stem Cell Transplantation

Shaohua Chen, Xin Huang, Haitao Zheng, Suxia Geng, Junyan Hu, Fan Zhang, Lijian Yang, Jianyu Weng, Xin Du, PhD, Yangqiu Li

Blood (2012) 120 (21): 4672.

https://doi.org/10.1182/blood.V120.21.4672.4672

Published: 2012

Journal Articles

A Clinical Study of Bone Marrow Stromal Cell Therapy in Patients with Refractory Cgvhd by Down-Regulating the Jagged2 Gene

Jianyu Weng, MD, Xin Huang, Suxia Geng, Chengwei Luo, Suijing Wu, Wei Ling, Rong Guo, Zesheng Lu, Chengxin Deng, Pengxiang Andy, Xin Du

Blood (2012) 120 (21): 4673.

https://doi.org/10.1182/blood.V120.21.4673.4673

Published: 2012

Journal Articles

Selective Targeting of B Cells with Mesenchymal Stromal Cells Treatment Is An Efficacious Strategy for Cutaneous Cgvhd,

Peilong Lai, Jianyu Weng, Chenwei Luo, Rong Guo, Zesheng Lu, Suxia Geng, Xin Du, PhD, Suijing Wu

Blood (2011) 118 (21): 4086.

https://doi.org/10.1182/blood.V118.21.4086.4086

Published: 2011

Journal Articles

Different Dosage of Bortezomib Impacts the Prevention of Acute Graft-Versus-Host Disease.

Jianyu Weng, MD, Meikun Lü, MD, Xin Du, PhD, Lin Xu, PhD, Suxia Geng, MD, Rong Guo, PhD, Suijin Wu, MD, Wei Ling, PhD, Yuchun Wang

Blood (2009) 114 (22): 4499.

https://doi.org/10.1182/blood.V114.22.4499.4499

Published: 2009

Journal Articles

Mesenchymal Stem Cells Relieve Chronic GVHD Via Modulation the Ratio of CD8+CD28-/CD8+CD28+T Cells.

Jianyu Weng, MD, Xin Du, PhD, Suxia Geng, MD, Maohua Zhou, MD, Yanwen Peng, Zhen Wang, Zesheng Lu, Suijing Wu, MD, Chenwei Luo, MD, Rong Guo, PhD, Wei Ling, PhD, Chengxin Deng, Pengjun Liao, Andy Peng Xiang, Ph.D

Blood (2009) 114 (22): 4501.

https://doi.org/10.1182/blood.V114.22.4501.4501

Published: 2009

NARROW

SRSF2 Mutation Cooperates with ASXL1 Mutation to Promote the Development of Myeloproliferative Variant of Chronic Myelomonocytic Leukemia

Single-Cell Analysis Reveals Altered Tumor Microenvironments of Relapse/ Refractory and Remission-Associated Acute Myeloid Leukemia Treated By ABC-14 Regimen

MRD-Driven Prophylactic or Pre-Emptive Intervention with Chidamide-Based Treatment for High-Risk AML Relapse Post-Transplantation: A Real-World Experience from a Chinese Single Center

Treatment-Free Remission Era: BCR-ABL1 mRNA Transcript Level <5% at 3 Months Predicts 24-Month Deep Molecular Response and Better Survival

Efficacy and Safety Analysis of Venetoclax Combined with Azacitidine in Real-World Treatment of Patients with AML

Multi-Omics Reveals Azacitidine Partially Restores Hematopoiesis-Supportive Functions in Mesenchymal Stromal Cells from Patients with Chronic Myelomonocytic Leukemia

Artesunate Attenuate Chronic Graft-Versus-Host Disease By Regulating Th17/Treg Balance

Comparison of the 5 Year Medical Outcome and Quality of Life of Patients with Chronic Myeloid Leukemia Treated with Imatinib or Allogeneic Transplant

Predictive Factors of Treatment Response to Hypomethylating Agents in Patients with Myelodysplastic Syndrome

Analysis of the Expression of PHTF1 and Related Genes in Acute Lymphoblastic Leukemia

The Expression of the Co-Inhibitory Molecule PD-1 and Its Ligand PD-L1 in Patients with MDS

Effects of Decitabine and Homoharringtonine in Combination in Leukemia Cell Lines

Persistent Clonal Expansion of Vδ3 and Vδ4 T Cells in T-ALL Case with Minimal Residual Disease after HSCT

CD8α + Jagged2 high CD11b high Regulatory Dendritic Cells Prevent Acute Gvhd

A New Murine Model Of Chronic Graft Versus Host Disease

The Evolution of Malignant and Reactive γδ+T Cell Clones in Relapse T-ALL After Allogeneic Stem Cell Transplantation

A Clinical Study of Bone Marrow Stromal Cell Therapy in Patients with Refractory Cgvhd by Down-Regulating the Jagged2 Gene

Selective Targeting of B Cells with Mesenchymal Stromal Cells Treatment Is An Efficacious Strategy for Cutaneous Cgvhd,

Different Dosage of Bortezomib Impacts the Prevention of Acute Graft-Versus-Host Disease.

Mesenchymal Stem Cells Relieve Chronic GVHD Via Modulation the Ratio of CD8+CD28-/CD8+CD28+T Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only